Phase II Amount
$1,493,232
SBIR Direct-to-Phase II Topic 340 encourages validation of mobile/wireless tools to support cancer prevention & control in clinical behavioral applications. Technologies may include wireless sensors, smartphone applications, behavioral analytics and decision support software or integrated platforms for health assessment, monitoring or intervention delivery. This topic is intended to clinically validate recently developed but not yet validated tools, in order to expand evidence of commercial potential and value.
NIH Spending Category: Behavioral and Social Science; Cancer; Clinical Research; Prevention
Project Terms: Adoption; Basic Science; Behavioral; Behavioral Research; cancer care; Cancer Control; cancer prevention; Cancer Survivor; Cellular Phone; Cessation of life; Chronic Disease; Clinical; clinical practice; Clinical Research; Computer software; cost; Diagnostic; Division of Cancer Control and Population Sciences; Evaluation; follow-up; Health; Health Technology; improved; Incidence; innovation; Intervention; lifestyle intervention; Malignant Neoplasms; Medical; Mission; Monitor; Phase; Quality of life; research and development; Risk; Risk Factors; screening; sensor; Small Business Innovation Research Grant; Technology; tool; Treatment Efficacy; Validation; Wireless Technology
